Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

Clinical trial NCT00350948 · TERMINATED

Trial details

NCT number: NCT00350948
Sponsor: Telik
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2006-05-01
Primary completion: 2008-12-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.